These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 5999513)

  • 1. [Changes of the serum protein pattern after antiblastic chemotherapy in advanced stages of ovarian carcinoma].
    Gilardi G; Vertova A
    Arch Ostet Ginecol; 1966; 71(6):681-94. PubMed ID: 5999513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the serum protein pattern after antiblastic chemotherapy of ovarian carcinoma in advanced stage].
    Gilardi G; Vertova A
    Minerva Ginecol; 1967 Aug; 19(16):799-801. PubMed ID: 5605080
    [No Abstract]   [Full Text] [Related]  

  • 3. [On quantitative changes in the leukocytes and thrombocytes after chemotherapy in patients with malignant tumors of the ovaries].
    Livshits MA
    Vopr Onkol; 1966; 12(8):42-6. PubMed ID: 4972210
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in erythropoiesis in patients with malignant tumors of the ovaries during chemotherapy].
    Bruk AA; Loskutova GP; Turbina IL
    Vopr Onkol; 1967; 13(12):21-3. PubMed ID: 4970401
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
    Israël L; Lepage E; Breau JL; Aguilera J
    Bull Cancer; 1982; 69(5):426-33. PubMed ID: 6891902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new therapeutic program in advanced ovarian cancer. Good results with decentralized cytostatic therapy].
    Henic E; Högberg T
    Lakartidningen; 1998 May; 95(22):2574-8. PubMed ID: 9640935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.
    Decker DG; Fleming TR; Malkasian GD; Webb MJ; Jeffries JA; Edmonson JH
    Obstet Gynecol; 1982 Oct; 60(4):481-7. PubMed ID: 6889714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of results obtained by various methods of cyclophosphamide therapy in advanced cancer of the ovary].
    Krommer K; Csaba I; Keller G
    Orv Hetil; 1976; 117(20):1205-7. PubMed ID: 1272567
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience.
    Ehrlich CE; Einhorn L; Stehman FB; Blessing J
    Clin Obstet Gynaecol; 1983 Aug; 10(2):325-35. PubMed ID: 6688562
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cytoprotective effect of Amifostine in the combined chemotherapy of advanced ovarian carcinoma].
    Nagy P; Kádasi L
    Orv Hetil; 2000 Sep; 141(37):2027-30. PubMed ID: 11037611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of advanced ovarian cancer.
    Casey MJ
    Conn Med; 1974 Jan; 38(1):1-3. PubMed ID: 4813666
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cytogenetic studies in the course of antiblastic therapy].
    Rugiati S; Ragni N; Sbernini R; De Cecco L
    Minerva Ginecol; 1967 Aug; 19(16):840-2. PubMed ID: 5629101
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy for ovarian cancer.
    Adlan A; Sen DK; Sivanesaratnam V
    Med J Malaysia; 1981 Sep; 36(3):159-65. PubMed ID: 7329372
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chromosome abnormalities in peripheral blood cells during treatment with cyclophosphamide for ovarian carcinoma].
    Zara C
    Arch Ostet Ginecol; 1968 Apr; 73(2):244-68. PubMed ID: 5706086
    [No Abstract]   [Full Text] [Related]  

  • 17. [The problem of accidental paravenous application of cytostatics--case history (author's transl)].
    Sommer H; Meinhold P
    Zentralbl Gynakol; 1981; 103(21):1324-8. PubMed ID: 6798785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
    Chylak V; Ilijas M; Krusić J; Kolarić K
    Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.
    Beck RE; Boyes DA
    Can Med Assoc J; 1968 Mar; 98(11):539-41. PubMed ID: 5647240
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer.
    Samaritani R; Corrado G; Vizza E; Sbiroli C
    BMC Cancer; 2007 Apr; 7():65. PubMed ID: 17433113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.